Patterson-UTI's stock soared 5.02% during intraday trading on Friday, driven by positive analyst actions that boosted investor sentiment.
Susquehanna raised its price target on Patterson-UTI to $10 from $8 while maintaining a Positive rating on the shares. RBC Capital also maintained a Buy rating on the stock with a price target of $9.00, and separately raised its price target to $9 from $8 while keeping an Outperform rating.
These analyst upgrades reflect growing optimism about Patterson-UTI's prospects, with the company receiving overweight ratings and price target increases from multiple financial institutions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.